Limbic epileptogenesis alters the anticonvulsant efficacy of phenytoin in Sprague-Dawley rats

Epilepsy Research

Volumn 31, Issue 3, 1998, Pages 175-186

  Löscher, Wolfgang ^a   Cramer, Sybille ^a   Ebert, Ulrich ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Kindling; Seizures

Indexed keywords

PHENYTOIN;

AFTERDISCHARGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPILEPTOGENESIS; FEMALE; LIMBIC CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TEMPORAL LOBE EPILEPSY;

AMYGDALA; ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPILEPSY; FEMALE; KINDLING, NEUROLOGIC; MALE; PHENYTOIN; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 0345698731     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-1211(98)00029-1     Document Type: Article

References (43)

1. Albertson T., Peterson S., Stark L. Effects of phenobarbital and SC-13504 on partially kindled seizures in rats. Exp. Neurol. 61:1978;270-280.
2. Albertson T.E., Peterson S.L., Stark L.G. The anticonvulsant effects of diazepam and phenobarbital in prekindled and kindled seizures in rats. Neuropharmacology. 20:1981;597-603.
3. Albright P.S. Effects of carbamazepine, clonazepam, and phenytoin on seizure threshold in amygdala and cortex. Exp. Neurol. 79:1983;11-17.
4. Bolwig, T.G., Trimble, M.R., 1989. The Clinical Relevance of Kindling. John Wiley & Sons, Chichester.
5. Cain, D.P., 1986. The transfer phenomenon in kindling. In: Wada, J.A. (Ed.), Kindling 3. Raven Press, New York, pp. 231-248.
6. Callaghan D.A., Schwark W.S. Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 19:1980;1131-1136.
7. DeLorenzo, R.J., 1995. Phenytoin. Mechanisms of action. In: Levy, R.H., Mattson, R.H., Meldrum, B.S. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 271-282.
8. Ebert U., Cramer S., Löscher W. Phenytoin's effect on the spread of seizure activity in the amygdala kindling model. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;341-347.
9. Freeman F.G., Jarvis M.F. The effect of interstimulation interval on the assessment and stability of kindled seizure threshold. Brain Res. Bull. 7:1981;629-633.
10. Frey H.-H., Löscher W., Reiche R., Schultz D. Anticonvulsant effect of primidone in the gerbil. Time course and significance of the active metabolites. Pharmacology. 28:1984;329-335.
11. Heinemann U., Draguhn A., Ficker E., Stabel J., Zhang C.L. Strategies for the development of drugs for pharmacoresistant epilepsies. Epilepsia. 35(Suppl. 5):1994;S10-S21.
12. Hönack D., Löscher W. Kindling increases the sensitivity of rats to adverse effects of certain antiepileptic drugs. Epilepsia. 36:1995;763-771.
13. Hvidberg, E.F., 1985. Monitoring antiepileptic drug levels. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 725-764.
14. Johannessen, S.I., Gram, L., Sillanpää, M., Tomson, T., 1995. Intractable Epilepsy. Wrightson Biomedical Publishing Ltd., Petersfield.
15. Jones, G.L., Wimbish, G.H., 1985. Hydantoins. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 351-420.
16. Jurna, I., 1985. Electrophysiological effects of antiepileptic drugs. In: Frey, H.-H., Janz, D. (Eds.), Antiepileptic Drugs. Springer, Berlin, pp. 611-658.
17. Lerman P. Seizures induced or aggravated by anticonvulsants. Epilepsia. 27:1986;706-710.
18. Levy L.L., Fenichel G.M. Diphenylhydantoin activated seizures. Neurology. 15:1965;716-722.
19. Löscher W. Basic aspects of epilepsy. Curr. Opin. Neurol. Neurosurg. 6:1993;223-232.
20. Löscher W. Animal models of intractable epilepsy. Prog. Neurobiol. 53:1997;239-258.
21. Löscher W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 342:1998;1-13.
22. Löscher W., Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
23. Löscher W., Hönack D. High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 341:1990;476-481.
24. Löscher W., Hönack D. Responses to NMDA receptor antagonists altered by epileptogenesis. Trends Pharmacol. Sci. 12:1991;52.
25. Löscher W., Rundfeldt C. Kindling as a model of drug-resistant partial epilepsy: selection of phenytoin-resistant and nonresistant rats. J. Pharmacol. Exp. Ther. 258:1991;483-489.
26. Löscher W., Schmidt D. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res. 17:1994;95-134.
27. Löscher W., Jäckel R., Czuczwar S.J. Is amygdala kindling in rats a model for drug-resistant partial epilepsy? Exp. Neurol. 93:1986;211-226.
28. Löscher W., Hönack D., Fassbender C.P., Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models. Epilepsy Res. 8:1991;171-189.
29. Löscher W., Rundfeldt C., Hönack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug-resistant partial epilepsy. Epilepsy Res. 15:1993;207-219.
30. McNamara J.O. Pursuit of the mechanisms of kindling. Trends Neurosci. 11:1988;33-36.
31. McNamara J.O. Cellular and molecular basis of epilepsy. J. Neurosci. 14:1994;3413-3425.
32. McNamara J.O., Rigsbee L.C., Butler L.S., Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann. Neurol. 26:1989;675-678.
33. Oscorio I., Burnstine T.H., Remler B., Manon-Espaillat R., Reed R.C. Phenytoin-induced seizures: a paradoxical effect at toxic concentrations in epileptic patients. Epilepsia. 30:1989;230-234.
34. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
35. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
36. Racine R.J., Livingston K., Joaquin A. Effects of procaine hydrochloride, diazepam, and diphenylhydantoin on seizure development in cortical and subcortical structures in rats. Electroencephalogr. Clin. Neurophysiol. 38:1975;355-365.
37. Rogawski M.A., Porter R.J. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
38. Rundfeldt C., Hönack D., Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 29:1990;845-851.
39. Sato M., Racine R.J., McIntyre D.C. Kindling: basic mechanisms and clinical validity. Electroencephalogr. Clin. Neurophysiol. 76:1990;459-472.
40. Schmidt, D., Morselli, P., 1986. Intractable Epilepsy: Experimental and Clinical Aspects. Raven Press, New York, NY.
41. Schmidt D., Einicke I., Haenel F. The influence of seizure type on the efficacy of plasma concentrations of phenytoin, phenobarbital, and carbamazepine. Arch. Neurol. 43:1986;263-265.
42. Wauquier A., Ashton D., Melis W. Behavioural analysis of amygdaloid kindling in Beagle dogs and the effects of clonazepam, diazepam, phenobarbital, diphenylhydantoin, and flunarizine on seizure manifestations. Exp. Neurol. 64:1979;579-586.
43. 3--ATPases and carbonic anhydrase of neonatal and adult cerebral cortex. Epilepsia. 26:1985;43-57.